The present invention provides antisense oligonucleotides directed to a mammalian ribonucleotide reductase R2 gene and combinations of the antisense oligonucleotides with one or more chemotherapeutic agents for use in the treatment of cancer.

 
Web www.patentalert.com

< Novel actin-associated cytosekeltone protein lacs

< Treatment of hyperproliferative disease

> Functional synthetic molecules and macromolecules for gene delivery

> Oligomeric compounds for use in gene modulation
~ 00298